Our results suggested that combined treatment with DIM and 5-Fu not only inactivated the Akt signaling pathway through the dephosphorylation of Akt and its downstream protein p-GSK-3β but also inhibited the Wnt signaling through inactivation of β-catenin in GC. The gene discussed is AKT1; the disease is gastric cancer.